Assays for hepatitis B surface antigen (HBsAg) are the most frequently ... testing and also to ascertain likely cause of weakly positive (grayzone) results. Results During the 17 month study ...

A dot plot showing COI for the HBsAg test for all 34 patients who received hepatitis B vaccine 14 days or less before HBsAg testing is shown in Figure 3. There was one patient who had a positive ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

By Dr. Liji Thomas, MD New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk patients. Study: AGA Clinical Practice Guideline on the ...

Breakthrough therapy designation recognises the potential of brelovitug to transform the lives of people living with CHD. We look forward to initiating a global pivotal trial a ...